About
Small molecules for movement disorders (Parkinson's akinesia/dyskinesia)
Areas of Focus
Categories
Small Molecule Pharmaceutical
Team (26)
Clinical Trials (11)
View allTotal Trials
11
As Lead Sponsor
10
As Collaborator
1
Total Enrollment
4,540
By Phase
NA: 4PHASE2: 4
By Status
COMPLETED: 6UNKNOWN: 3TERMINATED: 1RECRUITING: 1
Clinical Trials Pipeline11 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT07065110Lead Sponsor
The Effect of Peroral Sodium Hyaluronate on the Skin
NACompleted
150 participants
Started: Jun 17, 2024 · Completed: Dec 13, 2024
NCT05516875Lead Sponsor
Open-Label Extension Study of ASTORIA
PHASE2Terminated
6 participants
Started: Jan 19, 2024 · Completed: Jun 27, 2024
NCT06276270Lead Sponsor
Multi-centre, Open-label, First-in-man Study With Mucopad HA
NARecruiting
60 participants
Started: Dec 12, 2023 · Completed: Dec 31, 2024
NCT05618496Lead Sponsor
Multi-centre, Open-label, First-in-man Study With Epipad Used in Adult Patients
NACompleted
52 participants
Started: Oct 26, 2022 · Completed: Oct 31, 2023
NCT05625984Lead Sponsor
Study With Fascigel
NACompleted
55 participants
Started: Oct 24, 2022 · Completed: Nov 13, 2023
Locations (1)
Headquarters
Hørsholm, Denmark
Map
Loading map...